Insmed
INSM
141.33
-3.13
-2.17%
Insmed
US · INSM
#794 by market cap
Listed 1970
141.33
-3.13
-2.17%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions increased by 34 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.1 percentage points.
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 104.28% +0.10pp
- Institutions
- 865 +34
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund71.75%
Hedge Fund24.17%
Public Company2.52%
Private Company1.57%
Sovereign Wealth Fund1.57%
Government Pension Fund1.03%
Family Office/Trust0.68%
Individual/Insider0.62%
VC/PE Fund0.43%
Top holders as of 2026-06-30
BlackRock
7.21% · 15.81M sh
FMR
6.97% · 15.28M sh
Vanguard Capital Management, LLC
5.10% · 11.19M sh
Vanguard Portfolio Management, LLC
4.74% · 10.41M sh
J.P. Morgan Asset Management, Inc.
4.03% · 8.84M sh
Baker Bros. Advisors LP
4.01% · 8.80M sh
Capital Research
3.76% · 8.24M sh
Darwin Global Management Limited
2.93% · 6.43M sh
Columbia Management Investment Advisers, LLC
2.82% · 6.18M sh
Orbis Investment Management Limited
2.77% · 6.08M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 11 buys · 37 sells
| Name | Role | Stake |
|---|---|---|
| William Lewis | Chairperson & CEO | 0.17% |
| Melvin Sharoky | Independent Director | 0.12% |
| David Brennan | Lead Independent Director | 0.04% |
| David W. McGirr | Former Independent Director | 0.04% |
| Clarissa Desjardins | Independent Director | 0.03% |
| Carol Schafer | Independent Director | 0.03% |
| Roger Adsett | Chief Operating Officer | 0.03% |
| Elizabeth Anderson | Independent Director | 0.03% |
| John Wise | Former Chief Commercial Officer | 0.03% |
| Alfred Altomari | Former Independent Director | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-29 | Patrick Kane | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-10-18 | Paul Hudson | Independent Director | Other Acquisition | +6,139 | -- |
| 2026-10-18 | Utpal Koppikar | Independent Director | Other Acquisition | +6,139 | -- |
| 2026-09-08 | David Brennan | Lead Independent Director | Open Market Disposition | -25,000 | $124.00 |
| 2026-08-16 | Melvin Sharoky | Independent Director | Open Market Disposition | -5,000 | $127.53 |
| 2026-08-09 | Roger Adsett | Chief Operating Officer | Derivative Exercise and Sale | -239,850 | $13.67–133.27 |
| 2026-08-05 | Martina Flammer | Chief Medical Officer | Derivative Exercise and Sale | -27,173 | $18.95–129.40 |
| 2026-07-22 | William Lewis | Chairperson & CEO | Derivative Exercise and Sale | -10,700 | $17.16–106.43 |
| 2026-07-08 | William Lewis | Chairperson & CEO | Derivative Exercise and Sale | -10,699 | $17.16–118.52 |
| 2026-07-05 | Martina Flammer | Chief Medical Officer | Derivative Exercise and Sale | -12,302 | $19.74–110.60 |
| 2026-06-24 | William Lewis | Chairperson & CEO | Derivative Exercise and Sale | -21,398 | $17.16–106.27 |
| 2026-06-22 | Samuele Butera | Senior VP & GM of Global Respiratory | Other Acquisition | +7,342 | -- |
| 2026-06-22 | Samuele Butera | Senior VP & GM of Global Respiratory | Other Derivative Acquisition | +12,570 | $102.15 |
| 2026-06-21 | Michael Smith | Chief Legal Officer | Automatic Disposition | -1,806 | $95.82 |
| 2026-06-07 | William Lewis | Chairperson & CEO | Automatic Disposition | -6,515 | $94.03 |
| 2026-06-04 | Martina Flammer | Chief Medical Officer | Open Market Disposition | -4,424 | $102.27–103.78 |
| 2026-06-02 | William Lewis | Chairperson & CEO | Open Market Disposition | -7,605 | $102.27 |
| 2026-06-02 | Roger Adsett | Chief Operating Officer | Open Market Disposition | -2,370 | $102.27 |
| 2026-06-02 | Sara Bonstein | Former Chief Financial Officer | Open Market Disposition | -2,404 | $102.27 |
| 2026-06-02 | Michael Smith | Chief Legal Officer | Open Market Disposition | -2,159 | $102.27 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:34 · For reference only, not investment advice and not tailored to your situation.
Insmed discussion 0 comments